In addition, the expression of immune checkpoint molecules is significantly upregulated in patients with high DNAJC3 expression, which once again indicates that DNAJC3 expression is beneficial for the formation of an immunosuppressive tumor microenvironment. The gene discussed is DNAJC3; the disease is neoplasm.